(PDF) 273. Phase I Trial of Escalating Doses of SGT-53

273. Phase I Trial of Escalating Doses of SGT-53 Infusion in Combination With Docetaxel in Advanced Solid Tumor Patients

Molecular Therapy - United States

doi 10.1016/s1525-0016(16)34608-1

Full Text

Abstract

Available in full text

Categories

Molecular Medicine

Molecular Biology

Date

May 1, 2013

Authors

Unknown

Publisher

Elsevier BV

Related search

774. Phase Ib Trial of Escalating Doses of SGT-53 Infusion in Combination With Docetaxel in Advanced Solid Tumor Patients

Molecular Therapy

Molecular Medicine

Molecular Biology

English

A Phase I Dose-Escalation Study of Selumetinib in Combination With Docetaxel or Dacarbazine in Patients With Advanced Solid Tumors

Cancer Research

English

A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English

A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer

Investigational New Drugs

English

Phase I and Pharmacokinetic Study of Weekly Docetaxel, Cisplatin, and Daily Capecitabine in Patients With Advanced Solid Tumors

Clinical Cancer Research

Cancer Research

English

Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.

Journal of Clinical Oncology

Cancer Research

English

Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer

Urologic Oncology: Seminars and Original Investigations

English

A Phase I Trial of Intratumoral Administration of Recombinant Oncolytic Adenovirus Overexpressing HSP70 in Advanced Solid Tumor Patients

Molecular Medicine

Molecular Biology

English

A Multi-Arm Phase I Dose Escalating Study of an Oral NOTCH Inhibitor BMS-986115 in Patients With Advanced Solid Tumours

Investigational New Drugs

English